GALWAY, Ireland, Sept. 2, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced two U.S. Food and Drug Administration (FDA) regulatory milestones ...
Recently, researchers in Australia tested baricitinib, a drug used for rheumatoid arthritis, in people newly diagnosed with Type‑1 diabetes, showing promising results for early intervention.
For the growing number of children with type 1 diabetes, the daily burden of managing their challenging chronic disease and ...
Understanding what counts as normal, high, or low blood sugar is important as it explains how glucose works in the body, typical target ranges for children and adults, and why monitoring is essential.
“The whole sensor field is going to explode. It’s already exploding. It’s a little all over the place right now, but with the arc of time, it will become clearer I think,” said Apple CEO, Tim Cook, ...
LONDON--(BUSINESS WIRE)--DexCom, Inc. (Nasdaq: DXCM), a global leader in real-time continuous glucose monitoring (CGM) for people with diabetes, today announced both the launch of Dexcom ONE+, a CGM ...